Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN Cause Wrong product administered? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Wrong product administered have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 0.0% of all adverse event reports for DAPAGLIFLOZIN.

6
Reports of Wrong product administered with DAPAGLIFLOZIN
0.0%
of all DAPAGLIFLOZIN reports
3
Deaths
5
Hospitalizations

How Dangerous Is Wrong product administered From DAPAGLIFLOZIN?

Of the 6 reports, 3 (50.0%) resulted in death, 5 (83.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.

Is Wrong product administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does DAPAGLIFLOZIN Cause?

Death (2,775) Diabetic ketoacidosis (1,773) Acute kidney injury (982) Off label use (891) Nausea (884) Dehydration (860) Vomiting (838) Dizziness (817) Ketoacidosis (803) Fatigue (785)

What Other Drugs Cause Wrong product administered?

INSULIN LISPRO (337) INSULIN GLARGINE (226) RISPERIDONE (141) QUETIAPINE (137) ACETAMINOPHEN (133) INSULIN ASPART (112) CLOZAPINE (106) INSULIN HUMAN (104) TUBERCULIN PURIFIED PROTEIN DERIVATIVE (104) IBUPROFEN (102)

Which DAPAGLIFLOZIN Alternatives Have Lower Wrong product administered Risk?

DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN vs DAPRODUSTAT DAPAGLIFLOZIN vs DAPSONE DAPAGLIFLOZIN vs DAPTOMYCIN

Related Pages

DAPAGLIFLOZIN Full Profile All Wrong product administered Reports All Drugs Causing Wrong product administered DAPAGLIFLOZIN Demographics